DiaMedica Therapeutics Inc. (NASDAQ: DMAC)
$3.48
-0.1000 ( -2.79% ) 22.1K
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.
Market Data
Open
$3.48
Previous close
$3.58
Volume
22.1K
Market cap
$144.90M
Day range
$3.32 - $3.58
52 week range
$1.94 - $4.33
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-k | Annual reports | 88 | Mar 19, 2024 |
8-k | 8K-related | 16 | Mar 19, 2024 |
3 | Insider transactions | 2 | Jan 23, 2024 |
4 | Insider transactions | 1 | Jan 23, 2024 |
4 | Insider transactions | 1 | Jan 02, 2024 |
4 | Insider transactions | 1 | Jan 02, 2024 |
4 | Insider transactions | 1 | Jan 02, 2024 |
4 | Insider transactions | 1 | Jan 02, 2024 |
4 | Insider transactions | 1 | Jan 02, 2024 |
4 | Insider transactions | 1 | Nov 16, 2023 |